THROMBIN INHIBITORS

Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure:or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY2 or N;d is CY3 or N; e is CY4 or N; f is CY5 or N; g is CY6 or N; Y4, Y5, and Y6 are independe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STAUFFER, KENNETH, J, MORRISSETTE, MATTHEW, M, COBURN, CRAIG, LYLE, TERRY, A, DORSEY, BRUCE, D, NANTERMET, PHILIPPE, G, SANDERSON, PHILIP, E, WILLIAMS, PETER, D, STANTON, MATTHEW, G, SELNICK, HAROLD, G, STAAS, DONNETTE, ISAACS, RICHARD, NAYLOR-OLSEN, ADEL, M, BURGEY, CHRISTOPHER
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure:or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY2 or N;d is CY3 or N; e is CY4 or N; f is CY5 or N; g is CY6 or N; Y4, Y5, and Y6 are independently hydrogen, C1-4 alkyl, or halogen; Y1 and Y2 are independently hydrogen, C1-4 alkyl, C3-7 cycloalkyl, halogen, NH2, OH or C1-4 alkoxy, and Y3 is hydrogen, C1-4 alkyl, C3-7 cycloalkyl, halogen, -CN, NH2, OH or C1-4 alkoxy;A isand W, W1, R1, R3, R4, R5, X and Z are defined in the specification.